Align Technology Inc

Align Technology Inc. (ALGN) stock declined by 1.60% on Monday, closing at $140.42. This underperformance occurred on a mixed trading day, with the Dow Jones Industrial Average rising and the S&P 500 Index falling slightly. The stock's drop ended a two-day winning streak.

Argus has lowered its price target for Align Technology, Inc. (ALGN) to $134.00, citing its position as the leading manufacturer of clear aligners with Invisalign dominating over 90% of the market. The report provides a summary of ALGN's market position and is part of a larger collection of financial analyses.

Stifel has lowered its price target for Align Technology (ALGN) from $210 to $175. Despite this adjustment, the stock maintains an average "overweight" rating with a mean price target of $199.54 from analysts. The full MT Newswires article requires a premium subscription to access.

Align Technology Inc. (ALGN) saw its stock rise by 1.19% to $142.71 on Friday, outperforming the broader market. This gain occurred during a strong trading session where the S&P 500 Index increased by 0.59% and the Dow Jones Industrial Average rose by 0.83%. This marks the second consecutive day of gains for Align Technology Inc. stock.

Stifel has lowered its price target for Align Technology (ALGN) to $175 from $210. This adjustment follows a recent downgrade by Evercore ISI and other analyst adjustments for the company. Align Technology specializes in clear aligners and intra-oral scanners.

Stifel has lowered its price target for Align Technology Inc. (NASDAQ: ALGN) to $175 from $210, while maintaining a Buy rating, citing weak U.S. Invisalign demand. The firm noted poor patient conversion and volume trends among general practitioners and softness among orthodontists, leading to concerns about future earnings estimates despite the stock appearing undervalued by InvestingPro's Fair Value analysis. Other analysts like Evercore ISI have also downgraded the stock due to weakening consumer conditions and slowing demand.

Align Technology Inc.'s stock (ALGN) declined by 1.12% to $139.87 on Wednesday, underperforming the broader market as both the S&P 500 and Dow Jones Industrial Average also fell. Despite the daily loss, the article's title suggests it outperformed competitors, though this specific comparative data is not detailed in the provided text. The stock is currently trading 30.22% below its 52-week high of $200.44.

Align Technology's stock has fallen 77.7% over the past five years, but its current P/E ratio of 24.2x is slightly below the industry average, suggesting it's not overpriced given its earnings. The company, known for Invisalign, operates in a dental equipment market seeing growing demand for digital tools, which could support future profitability. Despite the past performance, the stock's current valuation appears reasonable when considering its earnings power and market position.

Align Technology (ALGN) has experienced a significant 77.7% share price drop over the past five years, leading investors to evaluate if its current valuation is justified by its earnings power. Despite this decline, the stock trades at a P/E ratio of 24.2x, slightly below the medical equipment industry average, suggesting it's not priced for exceptionally strong or weak prospects. The article also highlights that growing demand for digital dentistry tools could support future profitability for the company.

Align Technology (ALGN) shares have underperformed the S&P 500, losing 13.6% over the past six months. The article highlights three reasons for caution: disappointing long-term revenue growth (3.6% CAGR), barely growing EPS (1.4% CAGR), and declining Return on Invested Capital (ROIC). Despite a reasonable 11.9x forward P/E, the authors suggest better investment opportunities exist and recommend considering a fast-growing restaurant franchise instead.